Home › Funds › Parkman Healthcare Partners LLC › XERS
Parkman Healthcare Partners LLC position in XERS
XERIS BIOPHARMA HOLDINGS INC · Health Care
Parkman Healthcare Partners LLC reported holding 1,642,636 shares of XERS (XERIS BIOPHARMA HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$15.7M, representing 1.42% of its reported portfolio and ranking #25 among its reported holdings. Parkman Healthcare Partners LLC has disclosed XERS holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's XERS position evolved
Parkman Healthcare Partners LLC first disclosed a stake in XERS in Q1 2024 at 100,676 shares (US$222K). The position peaked in Q3 2026 at 1,642,636 shares, worth US$15.7M. Across 11 filings, Parkman Healthcare Partners LLC increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,642,636 shares valued at US$15.7M — a reduction of -164,985 shares quarter over quarter.. Notable position changes include a 465% increase in Q4 2024 (shares rose 62% over the following quarter), a 208% increase in Q1 2025 (shares fell 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 100.68K | $222.49K | New |
| Q2 2024 | 100.83K | $226.87K | Hold |
| Q3 2024 | 102.39K | $291.82K | Add |
| Q4 2024 | 578.51K | $1.96M | Add |
| Q1 2025 | 1.78M | $9.77M | Add |
| Q2 2025 | 2.11M | $9.84M | Add |
| Q3 2025 | 1.79M | $14.58M | Reduce |
| Q4 2025 | 1.69M | $13.28M | Reduce |
| Q1 2026 | 1.72M | $9.98M | Add |
| Q2 2026 | 1.81M | $14.32M | Add |
| Q3 2026 | 1.64M | $15.70M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About XERS and 13F data
XERS (XERIS BIOPHARMA HOLDINGS INC) is a Health Care company. 46 other funds we track also report a position in XERS — the largest reported positions include Polar Asset Management Partners Inc. (US$28.8M), Vilga Financial Planning LLC (US$10.1M), Knott David M Jr (US$9.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding XERS
- Polar Asset Management Partners Inc. 10.50M sh · $28.80M · Q2 2026
- Vilga Financial Planning LLC 1.06M sh · $10.13M · Q3 2026
- Knott David M Jr 1.00M sh · $9.59M · Q3 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 693.26K sh · $6.63M · Q3 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held XERS?
Parkman Healthcare Partners LLC has disclosed XERS holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Parkman Healthcare Partners LLC's current position in XERS?
As of Q3 2026, Parkman Healthcare Partners LLC holds 1.64M shares of XERS (XERIS BIOPHARMA HOLDINGS INC), valued at $15.70M, representing 1.42% of its reported portfolio and ranking #25.
Has Parkman Healthcare Partners LLC been buying or selling XERS?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in XERS. The position peaked in Q3 2026 at 1.64M shares.
Which other funds hold XERS?
Other major institutional holders of XERS include Polar Asset Management Partners Inc., Vilga Financial Planning LLC, Knott David M Jr, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.